Published in Funct Neurol on December 05, 2014
Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes (Basel) (2017) 0.75
Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD). BMC Neurol (2016) 0.75
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37
The electrocardiogram in population studies. A classification system. Circulation (1960) 11.86
Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med (2008) 4.65
Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology (2006) 2.14
Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord (1991) 1.75
Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord (2005) 1.48
Natural history of isolated bundle branch block. Am J Cardiol (1996) 1.46
A clinical and follow-up study of right and left bundle branch block. Circulation (1975) 1.43
The prevalence and prognostic significance of electrocardiographic abnormalities. Curr Probl Cardiol (2000) 1.21
Bundle-branch block in a general male population: the study of men born 1913. Circulation (1998) 1.18
Cardiomyopathy in muscular dystrophies. Curr Opin Neurol (2003) 1.12
PERSISTENT ATRIAL STANDSTILL. Am J Med (1965) 1.05
Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol (1990) 1.05
Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology (2004) 1.04
Induction and patterning of the cardiac conduction system. Int J Dev Biol (2002) 1.03
The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy. Muscle Nerve (1992) 1.00
Cardiac involvement in Becker muscular dystrophy. Can J Cardiol (2008) 0.93
His-Purkinje lineages and development. Novartis Found Symp (2003) 0.92
Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology (1998) 0.92
Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia. Eur Neurol (2006) 0.88
Persistent atrial standstill in a patient affected with facioscapulohumeral dystrophy. Cardiologia (1968) 0.88
Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photon-emission-computed tomography. J Neurol Sci (1996) 0.84
The heart in muscular dystrophy: an electrocardiographic and ultrasound study of 20 patients. Eur Arch Psychiatry Clin Neurosci (1991) 0.83
Intraventricular conduction disturbances in flying personnel: incomplete right bundle branch block. Aviat Space Environ Med (1988) 0.78
Right bundle branch block in a prospective population study. Cor Vasa (1983) 0.78
Low prevalence of ischemic electrocardiographic findings in a Danish population. Scand Cardiovasc J (2003) 0.77
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet (2011) 3.93
Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet (2012) 2.44
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J (2013) 2.37
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J (2005) 2.00
Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. J Am Coll Cardiol (2012) 1.98
Aortic root growth in men and women with the Marfan's syndrome. Am J Cardiol (2005) 1.85
Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet (2012) 1.62
Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum Mol Genet (2004) 1.49
Progression rate and early surgical experience in the new aggressive aneurysms-osteoarthritis syndrome. Ann Thorac Surg (2012) 1.41
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) (2014) 1.39
Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon. Europace (2011) 1.39
Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum (2011) 1.36
Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur J Hum Genet (2009) 1.33
Nucleoplasmic LAP2alpha-lamin A complexes are required to maintain a proliferative state in human fibroblasts. J Cell Biol (2007) 1.27
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma. Neuro Oncol (2006) 1.23
Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping. Hum Mutat (2010) 1.18
ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia. Neurogenetics (2008) 1.17
Bezafibrate for an inborn mitochondrial beta-oxidation defect. N Engl J Med (2009) 1.16
A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain (2012) 1.08
Age differences in neural correlates of route encoding and route recognition. Neuroimage (2004) 1.08
Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins. Biochim Biophys Acta (2010) 1.02
Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome. Int J Cardiol (2013) 1.00
The clinical spectrum of complete FBN1 allele deletions. Eur J Hum Genet (2010) 1.00
Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency. Neuromuscul Disord (2009) 0.98
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain (2013) 0.96
Obstetric complications in Marfan syndrome. Int J Cardiol (2005) 0.95
Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion (2011) 0.95
Localizing chronic Q fever: a challenging query. BMC Infect Dis (2013) 0.95
Troponin I release at rest and after exercise in patients with hypertrophic cardiomyopathy and the effect of betablockade. Arch Cardiol Mex (2007) 0.95
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients. Skelet Muscle (2011) 0.94
NMR imaging estimates of muscle volume and intramuscular fat infiltration in the thigh: variations with muscle, gender, and age. Age (Dordr) (2015) 0.94
Evaluation of left ventricular dimensions and function in Marfan's syndrome without significant valvular regurgitation. Am J Cardiol (2005) 0.93
Intrinsic biventricular dysfunction in Marfan syndrome. Heart (2011) 0.92
Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study. Acta Neuropathol (2009) 0.91
Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy. PLoS One (2011) 0.89
Pulmonary vein isolation during cryoballoon ablation using the novel Achieve inner lumen mapping catheter: a feasibility study. Europace (2012) 0.89
Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) (2012) 0.89
Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord (2012) 0.88
Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuria. J Mol Biol (2005) 0.88
A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patient. J Neurol (2011) 0.87
Inflammation aggravates disease severity in Marfan syndrome patients. PLoS One (2012) 0.87
High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology (2012) 0.87
Comparison of aortic elasticity in patients with the marfan syndrome with and without aortic root replacement. Am J Cardiol (2003) 0.86
191st ENMC international workshop: recent advances in oculopharyngeal muscular dystrophy research: from bench to bedside 8-10 June 2012, Naarden, The Netherlands. Neuromuscul Disord (2013) 0.85
Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use. J Rheumatol (2012) 0.84
Manual segmentation of individual muscles of the quadriceps femoris using MRI: a reappraisal. J Magn Reson Imaging (2013) 0.83
A clinical appraisal of different Z-score equations for aortic root assessment in the diagnostic evaluation of Marfan syndrome. Genet Med (2013) 0.83
An FBN1 deep intronic mutation in a familial case of Marfan syndrome: an explanation for genetically unsolved cases? Hum Mutat (2014) 0.83
A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. J Neurol (2013) 0.83
Symptomatic lipid storage in carriers for the PNPLA2 gene. Eur J Hum Genet (2012) 0.82
Increased prevalence of migraine in Marfan syndrome. Int J Cardiol (2008) 0.81
The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet (2017) 0.81
Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome. Gene (2013) 0.80
Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillance. Radiology (2013) 0.79
Quadriceps weakness in a family with nemaline myopathy: influence of knee angle. Clin Sci (Lond) (2003) 0.79
Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome. Circ J (2013) 0.79
Confirmation that abnormal desmin accumulation and migration are due to a desmin gene mutation in a familial cardiomyopathy and distal myopathy. Neuromuscul Disord (2009) 0.79
Eosinophilic fasciitis in a child mimicking a myopathy. Neuromuscul Disord (2006) 0.78
Multifocal motor neuropathy. Curr Opin Neurol (2005) 0.76
Classification of employment factors according to the International Classification of Functioning, Disability and Health in patients with neuromuscular diseases: a systematic review. Disabil Rehabil (2009) 0.76
Efficacy of rituximab in refractory and relapsing myositis with anti-JO1 antibodies: a report of two cases. Rheumatology (Oxford) (2009) 0.76
Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab (2011) 0.76
Correction: Cervical Spinal Cord Atrophy Profile in Adult SMN1-Linked SMA. PLoS One (2016) 0.75
Problems of adults with a mitochondrial disease - the patients' perspective: focus on loss. JIMD Rep (2012) 0.75
Re: Cervical myelopathy caused by retrograde intraneural dissection of anesthetic solution. Muscle Nerve (2008) 0.75
Auditory processing in patients with Charcot-Marie-Tooth disease type 1A. Otol Neurotol (2003) 0.75
Postirradiation neuromyotonia of spinal accessory nerves. Neurology (2011) 0.75
The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet (2017) 0.75
Investigation of a family following fulminant malignant hyperthermia. J Clin Neuromuscul Dis (2004) 0.75
Consent: a Cartesian ideal? Human neural transplantation in Parkinson's disease. Med Law (2003) 0.75
Contractile properties of knee-extensors in one single family with nemaline myopathy: central and peripheral aspects of muscle activation. Clin Physiol Funct Imaging (2007) 0.75
Focal necrotizing myopathy with 'dropped-head syndrome' induced by cobimetinib in metastatic melanoma. Melanoma Res (2017) 0.75